Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

European Patient Summary

Patient
Name: Campbell, Mary
DOB: 10-JUL-1986 (Age: 39)
Gender: female
ID: 7109-977837-6 (ECI)
Author
Dr. Ping, Hel
Patient summary Document
European Patient Summary
Report Date: 06-APR-2023

Problem list

Condition Onset Date Status
Osteoarthritis of knee 25-Oct-2018 active

Medication list

No known medications

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 17-Apr-2025
Hepatitis A virus antigen only vaccine product 11-Apr-2024
Clostridium tetani toxoid antigen adsorbed only vaccine product 11-Apr-2024
SARS-CoV-2 mRNA vaccine 18-Mar-2021

Procedure History list

Procedure Date Reason
Suture open wound 22-Mar-2024 Laceration of thigh
Depression screening 12-May-2022 -
Medication reconciliation 12-May-2022 -
Assessment of health and social care needs 12-May-2022 -
Screening for drug abuse 12-May-2022 -
Screening for domestic abuse 12-May-2022 -
Assessment of substance use 12-May-2022 -
Depression screening using Patient Health Questionnaire Two-Item score (procedure) 12-May-2022 -
Postoperative care 06-Dec-2018 History of tubal ligation (situation)
Ligation of bilateral fallopian tubes 05-Dec-2018 Sterilization requested (situation)

Allergies and Intolerances

Allergy/Intolerance Onset Date Status Type Reaction
? active ?

Care Plan

Active Planned Care / Goals Start Date Reason
Musculoskeletal care 25-Oct-2018 Osteoarthritis of knee
  • Reduce knee pain severity to mild or less
  • Increase ability to walk without significant limitation
  • Engage in moderate physical activity at least 150 minutes per week

Vital Signs

Vital Signs 2025-04-17 2024-04-11
Body Height 172.4 cm 172.4 cm
Pain severity - 0-10 verbal numeric rating [Score] - Reported 0 {score} 3 {score}
Body Weight 89.6 kg 89.6 kg
Body mass index (BMI) [Ratio] 30.2 kg/m2 30.2 kg/m2
Diastolic Blood Pressure 80 mm[Hg] 85 mm[Hg]
Systolic Blood Pressure 117 mm[Hg] 118 mm[Hg]
Heart rate 85 /min 70 /min
Respiratory rate 13 /min 14 /min

Relevant diagnostic tests/laboratory data

Recent Lab Observations 06-APR-2023 Reference Range Unit
Cholesterol [Mass/volume] in Serum or Plasma 170.4 130 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 109.5 35 - 150 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 94.5 0 - 130 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 54.0 40 - 60 mg/dL

Device Use

Device Date (since)
Walker (physical object) 25-Oct-2018